scholarly article | Q13442814 |
P356 | DOI | 10.1002/CPDD.360 |
P698 | PubMed publication ID | 28597973 |
P2093 | author name string | Toshitaka Yajima | |
Hitoshi Shimada | |||
Hyosung Kim | |||
Catarina Nilsson | |||
Torbjörn Lundström | |||
Yoshinori Noda | |||
P2860 | cites work | Overview of prescription omega-3 fatty acid products for hypertriglyceridemia | Q28251391 |
Serum triglycerides and risk of coronary heart disease among Japanese men and women | Q32066276 | ||
Executive summary of the Japan Atherosclerosis Society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan -2012 version | Q34344173 | ||
Omega-3 carboxylic acids (Epanova): a review of its use in patients with severe hypertriglyceridemia | Q34439420 | ||
Triglycerides and remnant particles as risk factors for coronary artery disease | Q34498572 | ||
Comparison of various lipid variables as predictors of coronary heart disease in Japanese men and women with type 2 diabetes: subanalysis of the Japan Diabetes Complications Study | Q35898244 | ||
Steady-state bioavailability of prescription omega-3 on a low-fat diet is significantly improved with a free fatty acid formulation compared with an ethyl ester formulation: the ECLIPSE II study | Q37225366 | ||
Epanova(®) and hypertriglyceridemia: pharmacological mechanisms and clinical efficacy | Q38086841 | ||
Development and validation of a sensitive and selective UHPLC-MS/MS method for simultaneous determination of both free and total eicosapentaeonic acid and docosahexenoic acid in human plasma | Q42845775 | ||
Highly purified eicosapentaenoic acid reduces cardio-ankle vascular index in association with decreased serum amyloid A-LDL in metabolic syndrome | Q43274967 | ||
Incremental effects of eicosapentaenoic acid on cardiovascular events in statin-treated patients with coronary artery disease | Q43698602 | ||
Triglyceride and glucose intolerance as a risk factor for coronary heart disease | Q43762941 | ||
Eicosapentaenoic acid improves endothelial function in hypertriglyceridemic subjects despite increased lipid oxidizability | Q44227550 | ||
Effects of eicosapentaenoic acid on platelet activation markers and cell adhesion molecules in hyperlipidemic patients with Type 2 diabetes mellitus | Q44434979 | ||
Omega-3 free fatty acids for the treatment of severe hypertriglyceridemia: the EpanoVa fOr Lowering Very high triglyceridEs (EVOLVE) trial | Q46919603 | ||
Fasting triglyceride is a significant risk factor for coronary artery disease in middle-aged Japanese men. | Q46963223 | ||
Mortality risk of triglyceride levels in patients with coronary artery disease. | Q50908726 | ||
Impact of hypertriglyceridemia on endothelial dysfunction during statin ± ezetimibe therapy in patients with coronary heart disease. | Q51373690 | ||
Effects of Docosahexaenoic Acid on the Endothelial Function in Patients with Coronary Artery Disease | Q57711672 | ||
Increased triglyceride may determine the sites of coronary arterial lesions | Q68616112 | ||
Plasma lipid abnormalities and risk factors for coronary artery disease in Japanese subjects with diabetes mellitus and glucose intolerance | Q72554117 | ||
The long-term effect of eicosapentaenoic acid on serum levels of lipoprotein (a) and lipids in patients with vascular disease | Q73514453 | ||
A novel omega-3 free fatty acid formulation has dramatically improved bioavailability during a low-fat diet compared with omega-3-acid ethyl esters: the ECLIPSE (Epanova(®) compared to Lovaza(®) in a pharmacokinetic single-dose evaluation) study | Q85891128 | ||
Eicosapentaenoic Acid combined with optimal statin therapy improves endothelial dysfunction in patients with coronary artery disease | Q86585432 | ||
P433 | issue | 2 | |
P921 | main subject | placebo | Q269829 |
phase I clinical trial | Q5452194 | ||
P304 | page(s) | 177-187 | |
P577 | publication date | 2017-06-09 | |
P1433 | published in | Clinical pharmacology in drug development | Q27726600 |
P1476 | title | Safety, Tolerability, and Pharmacokinetics of Single and Multiple Oral Doses of an Omega-3-Carboxylic Acid Formulation in Healthy Male Japanese Subjects: A Phase 1 Single-Blind, Randomized, Placebo-Controlled Trial. | |
P478 | volume | 7 |
Q96610645 | Pharmacokinetics of Single and Multiple Doses of Omega-3 Carboxylic Acids in Healthy Chinese Subjects: A Phase I, Open-Label Study | cites work | P2860 |
Search more.